Mitochondrial SASP Aging Inflammation Pathway Study
Analysis based on 6 articles · First reported Aug 20, 2026 · Last updated Sep 14, 2026
The findings open a potential new therapeutic avenue for age-related inflammatory diseases, which could benefit biotechnology and pharmaceutical companies pursuing senolytic and anti-aging drug development. Near-term market impact is limited because the results are preclinical mouse data with no approved product, though they may lift sentiment toward longevity-focused biotech and research institutions.
Researchers at Sanford Burnham Prebys, Mayo Clinic and international collaborators published findings in Nature (journal) on July 29, 2026, revealing a previously unknown mechanism linking dysfunctional mitochondria to chronic age-related inflammation. The study shows that senescent zombie cells accumulate with age and remain metabolically active, releasing inflammatory molecules through the senescence-associated secretory phenotype (SASP). Two mitochondrial pathways converge to drive this process: elevated acetyl-CoA production loosens histone packaging to expose inflammatory genes, while DNA and RNA leaked from damaged mitochondria activate immune transcription factors that switch those genes on. Led by senior author Joao F. Passos of Mayo Clinic and co-corresponding author Peter D. Adams of Sanford Burnham Prebys, with Helene Martini as first author, the team found that blocking the mitochondrial citrate transporter SLC25A1 with the drug CTPI-2 reduced acetyl-CoA levels, suppressed inflammation across tissues, and improved tissue function and healthspan in aging mice, even though the immune alarm signals remained. The work suggests a novel therapeutic strategy of targeting metabolic signals that control DNA accessibility to mitigate age-associated inflammation and functional decline without destroying senescent cells. Contributing institutions include Imperial College London, Albert Einstein College of Medicine and University of Glasgow. The study was supported by the United States — National Institutes of Health, United States — National Institute on Aging, United States — National Cancer Institute, United States — National Institute of Diabetes and Digestive and Kidney Diseases, United States — United States Department of Defense, Hevolution Foundation, Loo and Hans Osterman Foundation for Medical Research, Cancer Research UK and Robert and Arlene Kogod Center on Aging.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard